Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGylated recombinant human growth hormone injection in short children born small for gestational age
CTR20171111Phase 2Active
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of peg-somatropin in Short stature in children born small for gestational age, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Jan 2017; status: active.
02
Drugs
peg-somatropin
03
Conditions
Short stature in children born small for gestational age
Beyond the preview
Go deeper on CTR20171111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171111.